Skip to main content
Gil Redelman-Sidi, MD, Infectious Disease, New York, NY

Gil Redelman-Sidi MD


Physician

Request Appointment
  • 530 East 74th StreetNew York, NY 10021

  • Book by Phone+1(205) 843-1895

Overview of  Dr. Redelman-Sidi

Dr. Gil Redelman-Sidi is an infectious disease specialist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Tel Aviv University Sackler and has been in practice 17 years. He is one of 32 doctors at Memorial Sloan Kettering Cancer Center who specialize in Infectious Disease. He has more than 20 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2008 - 2011
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2008
  • Tel Aviv University Sackler
    Tel Aviv University SacklerClass of 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NJ State Medical License
    NJ State Medical License 2023 - 2027
  • NY State Medical License
    NY State Medical License 2007 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • New Understanding of a Decades-Old Bladder Cancer Treatment Could Help Improve Immunotherapies More Broadly
    New Understanding of a Decades-Old Bladder Cancer Treatment Could Help Improve Immunotherapies More BroadlyMay 29th, 2025
  • BCG Immunotherapy Reprograms Bone Marrow to Boost Cancer Defense
    BCG Immunotherapy Reprograms Bone Marrow to Boost Cancer DefenseMay 28th, 2025
  • New Insights into Decades-Old Bladder Cancer Treatment Offers Clues for Immunotherapy
    New Insights into Decades-Old Bladder Cancer Treatment Offers Clues for ImmunotherapyMay 28th, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: